Roblin X, Nancey S, Papamichael K, Duru G, et al. Higher serum infliximab concentrations following subcutaneous dosing are associated with deep remission in patients with inflammatory bowel disease. J Crohns Colitis 2023 Nov 2:jjad188. doi: 10.1093.
PMID: 37934041